Dr. Martens Plc · LSE:DOCS

Dr. Martens — Shareholder Meeting (July 2025)

12 slides from Dr. Martens's shareholder meeting presentation, Jul 10, 2025

  1. Slide 1: AGM Trading Update

    AGM TRADING UPDATE 10 JULY 2025 DR. MARTENS PLC

  2. Slide 2: Summary Financials

    SUMMARY FINANCIALS % change FY25 FY25 Constant FY24 £m Reported currency Reported Reported Constant currency Pairs (m) 10.5 10.5 11.5 -9% -9% Revenue 787.6 804.8 877.1 -10% -8% Gross Margin 511.7 524.8 575.2 -11% -9% Gross Margin % 65.0% 65.2% 65.6% -0.6pts -0.4pts Opex2 (378.4) (383.8) (377.7) 0% 2

  3. Slide 3: Strategy

    STRATEGY

  4. Slide 4: Channel First to Consumer First

    FROM TO CHANNEL CONSUMER FIRST FIRST “BUILD IT AND THEY WILL COME” “EARN THE RIGHT WITH EACH WEARER”

  5. Slide 5: To be the world's most desired premium footwear brand

    AMBITION TO BE THE WORLD’S MOST DESIRED PREMIUM FOOTWEAR BRAND

  6. Slide 6: Our Levers for Growth

    OUR LEVERS FOR GROWTH CONSUMER PRODUCT MARKETS ORGANISATION

  7. Slide 7: Buzz Case Study

    BUZZ CASE STUDY + CONSUMER: 56% of Buzz purchasers were new to the brand + PRODUCT: Bestselling product with global sell-through >75% by week 3 + MARKETS: Key wholesale accounts sell-through in 2 weeks, leading to additional purchases for AW25 + ORGANISATION: Cross functional working throughout the

  8. Slide 8: Medium-Term Financial Targets

    MEDIUM-TERM FINANCIAL TARGETS + PROFITABLE REVENUE GROWTH ABOVE THE RATE OF THE RELEVANT FOOTWEAR MARKET + OPERATIONAL LEVERAGE TO DRIVE MID TO HIGH TEENS EBIT MARGIN + UNDERPINNED BY STRONG CASH GENERATION

  9. Slide 9: FY26 Objectives

    FY26 OBJECTIVES CONSUMER PRODUCT REDUCE THE RELIANCE ON DISCOUNTED DRIVE PAIRS GROWTH IN PRODUCT (“OFF-PRICE”) PAIRS IN AMERICAS FAMILIES SUCH AS BUZZ, ZEBZAG AND WHOLESALE LOWELL MARKETS ORGANISATION OPEN IN NEW MARKETS THROUGH A SIMPLIFY OUR OPERATING MODEL CAPITAL-LIGHT STRUCTURE

  10. Slide 10: AGM Trading Update

    AGM TRADING UPDATE + Trading in line with expectations, FY26 guidance unchanged + By Region: + We continue to see positive trading in our Americas DTC channel driven by full price sales, particularly in retail + EMEA DTC remains variable with the UK continuing to have a challenging trading backdrop

  11. Slide 11: Q&A

    Q&A

  12. Slide 12: Dr. Martens plc

    Dr. Martens plc drmartensofficial

Dr. Martens — Shareholder Meeting (July 2025) on 6ix